TLR4 and familial avascular necrosis of femoral head: Mongolicin can regulate inflammation and promote bone formation by inhibiting the TLR4/NF-κB pathway and M1 macrophage polarization, reducing the incidence of femoral head osteonecrosis and alleviating pathological manifestations within the femoral head (35).